This Bull Market Indicator called NVDA at $116

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here

HUMA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.20%

Insider Buying (Last 12 Months): $369,107.20

Insider Selling (Last 12 Months): $25,940,916.90

Humacyte Insider Trading History Chart

Humacyte Share Price & Price History

^$4.41

▼ -0.01 (-0.23%)

As of 11/20/2024 01:00 AM ET

Days: 30 | 90 | 365

Breaking News: Tesla headed to $500…

From WealthPress | Ad

That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address.

Humacyte Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/20/2024	Laura E. Niklason	CEO	Sell	261,369	$4.40	$1,150,023.60	1,730,884
11/19/2024	Brady W. Dougan	Director	Sell	427,459	$4.34	$1,855,172.06	1,992,253
11/18/2024	Laura E. Niklason	CEO	Sell	811,172	$4.44	$3,601,603.68	2,419,712
9/10/2024	Kathleen Sebelius	Director	Sell	5,182	$5.40	$27,982.80	40,276
9/9/2024	Laura E. Niklason	CEO	Sell	157,704	$5.42	$854,755.68	3,519,558
8/29/2024	Brady W. Dougan	Director	Sell	352,112	$6.35	$2,235,911.20	3,677,262
8/28/2024	Laura E. Niklason	CEO	Sell	277,090	$6.47	$1,792,772.30	4,029,374
8/27/2024	Brady W. Dougan	Director	Sell	252,676	$6.71	$1,695,455.96	4,306,464
8/27/2024	Dale A Sander	CFO	Sell	39,389	$6.68	$263,118.52	2,000
6/12/2024	Brady W. Dougan	Director	Sell	271,518	$7.30	$1,982,081.40	4,559,140
6/11/2024	Laura E. Niklason	CEO	Sell	358,630	$7.08	$2,539,100.40	4,830,658
6/4/2024	Brady W. Dougan	Director	Buy	2,362	$6.35	$14,998.70	240,832
6/3/2024	Laura E. Niklason	CEO	Buy	2,050	$7.37	$15,108.50	238,470
5/31/2024	Laura E. Niklason	CEO	Sell	809,786	$7.91	$6,405,407.26	5,381,354
5/30/2024	Heather Ledbetter Prichard	COO	Sell	188,886	$8.14	$1,537,532.04	2,625
5/15/2024	Gordon M Binder	Director	Buy	50,000	$6.78	$339,000.00	160,000
9/14/2023	Laura E. Niklason	CEO	Sell	2,000,000	$2.78	$5,560,000.00	6,191,140
8/21/2023	Laura E. Niklason	CEO	Sell	602,443	$3.39	$2,042,281.77	8,191,140
8/18/2023	Brady W. Dougan	Director	Sell	626,979	$3.57	$2,238,315.03	8,793,583
8/17/2023	Laura E. Niklason	CEO	Sell	570,174	$3.68	$2,098,240.32	9,420,562
6/15/2023	Laura E. Niklason	CEO	Sell	500,000	$3.12	$1,560,000.00	9,990,736
6/13/2023	Laura E. Niklason	CEO	Sell	4,875,000	$2.60	$12,675,000.00	10,490,736
5/25/2023	Heather Ledbetter Prichard	COO	Sell	9,613	$3.83	$36,817.79	64,566
5/25/2023	Laura E. Niklason	CEO	Sell	2,625,000	$2.75	$7,218,750.00	15,365,736
12/16/2022	Brady W. Dougan	Director	Sell	239,538	$2.53	$606,031.14	17,990,736
12/16/2022	Dale A Sander	CFO	Buy	20,000	$2.60	$52,000.00	20,600
12/15/2022	Laura E. Niklason	CEO	Sell	93,426	$2.63	$245,710.38	18,230,274
12/14/2022	Brady W. Dougan	Director	Sell	276,304	$2.76	$762,599.04	18,323,700
12/13/2022	Laura E. Niklason	CEO	Sell	330,000	$2.84	$937,200.00	18,600,004
12/13/2022	William John Scheessele	Insider	Buy	5,000	$3.09	$15,450.00	15,525
9/15/2022	Brady W. Dougan	Director	Sell	1,522,500	$4.00	$6,090,000.00	18,930,004
9/15/2022	Laura E. Niklason	CEO	Buy	2,000	$4.14	$8,280.00	1,160,240
5/24/2022	William John Scheessele	Insider	Buy	10,525	$4.72	$49,678.00	10,525
5/23/2022	Laura E. Niklason	CEO	Buy	10,000	$4.83	$48,300.00	1,158,240
5/23/2022	Michael T. Constantino	Director	Buy	2,000	$4.83	$9,660.00	4,500
5/17/2022	Dale A Sander	CFO	Buy	2,000	$4.53	$9,060.00	2,000
12/16/2021	Brady W. Dougan	Director	Sell	75,000	$9.00	$675,000.00
12/15/2021	Laura E. Niklason	CEO	Sell	125,000	$8.88	$1,110,000.00
12/14/2021	Brady W. Dougan	Director	Sell	100,000	$9.44	$944,000.00
11/22/2021	Michael T. Constantino	Director	Buy	2,500	$10.79	$26,975.00

Blackrock’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW

SEC Filings (Institutional Ownership Changes) for Humacyte (NASDAQ:HUMA)

44.71% of Humacyte stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Humacyte Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/20/2024	Virtu Financial LLC	40,102	$0.22M	0.0%	-61.1%	0.032%
11/19/2024	Barclays PLC	236,742	$1.29M	0.0%	+177.6%	0.188%
11/16/2024	Geode Capital Management LLC	2,040,218	$11.10M	0.0%	+9.6%	1.709%
11/15/2024	Barclays PLC	236,742	$1.29M	0.0%	+177.6%	0.198%
11/15/2024	XTX Topco Ltd	34,049	$0.19M	0.0%	+48.8%	0.029%
11/15/2024	Insigneo Advisory Services LLC	20,000	$0.11M	0.0%	N/A	0.017%
11/15/2024	Wellington Management Group LLP	254,411	$1.38M	0.0%	+30.9%	0.213%
11/15/2024	State Street Corp	4,764,155	$25.92M	0.0%	+66.1%	3.992%
11/15/2024	Janus Henderson Group PLC	36,900	$0.20M	0.0%	N/A	0.031%
11/14/2024	Verition Fund Management LLC	90,240	$0.49M	0.0%	+459.1%	0.076%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	109,542	$0.60M	0.0%	N/A	0.092%
11/14/2024	FORA Capital LLC	17,731	$96K	0.0%	N/A	0.015%
11/13/2024	FMR LLC	94,387	$0.51M	0.0%	+28.5%	0.079%
11/13/2024	The Manufacturers Life Insurance Company	45,575	$0.25M	0.0%	+30.5%	0.038%
11/12/2024	Charles Schwab Investment Management Inc.	721,318	$3.92M	0.0%	+10.2%	0.604%
11/9/2024	Intech Investment Management LLC	42,615	$0.23M	0.0%	N/A	0.036%
11/7/2024	Thrivent Financial for Lutherans	130,894	$0.71M	0.0%	N/A	0.110%
11/5/2024	Victory Capital Management Inc.	76,896	$0.42M	0.0%	+551.6%	0.064%
11/5/2024	GSA Capital Partners LLP	120,318	$0.66M	0.0%	-46.3%	0.101%
10/31/2024	Concurrent Investment Advisors LLC	13,800	$75K	0.0%	N/A	0.012%
10/25/2024	China Universal Asset Management Co. Ltd.	22,955	$0.13M	0.0%	+64.1%	0.019%
10/22/2024	Private Advisor Group LLC	373,110	$2.03M	0.0%	+1.8%	0.313%
10/21/2024	Wealth Effects LLC	64,200	$0.35M	0.1%	N/A	0.054%
10/3/2024	SG Americas Securities LLC	32,074	$0.17M	0.0%	N/A	0.027%
8/15/2024	The Manufacturers Life Insurance Company	34,919	$0.17M	0.0%	+32.5%	0.029%
8/15/2024	Millennium Management LLC	1,599,307	$7.68M	0.0%	+504.3%	1.343%
8/15/2024	Deerfield Management Company L.P. Series C	322,851	$1.55M	0.0%	N/A	0.271%
8/15/2024	AQR Capital Management LLC	256,342	$1.23M	0.0%	+1,018.4%	0.215%
8/14/2024	Squarepoint Ops LLC	68,319	$0.33M	0.0%	-25.7%	0.057%
8/14/2024	Marshall Wace LLP	463,662	$2.23M	0.0%	+3,301.5%	0.389%
8/14/2024	Bank of Montreal Can	98,601	$0.50M	0.0%	N/A	0.083%
8/14/2024	ProShare Advisors LLC	15,554	$75K	0.0%	-14.8%	0.013%
8/14/2024	Profund Advisors LLC	20,271	$97K	0.0%	N/A	0.017%
8/12/2024	XTX Topco Ltd	22,877	$0.11M	0.0%	N/A	0.019%
8/9/2024	Renaissance Technologies LLC	600,300	$2.88M	0.0%	+693.0%	0.504%
8/5/2024	Private Advisor Group LLC	366,600	$1.76M	0.0%	+15.4%	0.308%
8/2/2024	Endowment Wealth Management Inc.	100,518	$0.48M	0.4%	+3.1%	0.084%
8/1/2024	Rhumbline Advisers	110,919	$0.53M	0.0%	+87.8%	0.093%
8/1/2024	United Asset Strategies Inc.	218,308	$1.05M	0.1%	-1.5%	0.183%
7/31/2024	nVerses Capital LLC	5,900	$28K	0.0%	N/A	0.005%
7/29/2024	Principal Financial Group Inc.	17,196	$83K	0.0%	N/A	0.014%
7/26/2024	Bank of New York Mellon Corp	254,013	$1.22M	0.0%	+62.7%	0.213%
7/24/2024	Bay Colony Advisory Group Inc d b a Bay Colony Advisors	14,550	$70K	0.0%	-35.2%	0.012%
7/17/2024	ARS Investment Partners LLC	116,419	$0.56M	0.1%	N/A	0.098%
5/20/2024	Virtu Financial LLC	63,403	$0.20M	0.0%	N/A	0.053%
5/14/2024	Anson Funds Management LP	50,000	$0.16M	0.0%	N/A	0.042%
5/10/2024	Vanguard Group Inc.	4,019,681	$12.50M	0.0%	+28.7%	3.376%
5/3/2024	GSA Capital Partners LLP	199,049	$0.62M	0.0%	-54.5%	0.167%
5/1/2024	Capstone Investment Advisors LLC	312,400	$0.97M	0.0%	N/A	0.262%
4/30/2024	Private Advisor Group LLC	317,624	$0.99M	0.0%	+232.7%	0.267%
4/30/2024	Hartline Investment Corp	22,450	$70K	0.0%	N/A	0.019%
4/29/2024	China Universal Asset Management Co. Ltd.	19,883	$62K	0.0%	+65.9%	0.017%
4/23/2024	Seven Grand Managers LLC	50,000	$0.16M	0.1%	N/A	0.042%
2/13/2024	Tower Research Capital LLC TRC	8,989	$26K	0.0%	+261.7%	0.009%
2/7/2024	Kovitz Investment Group Partners LLC	12,250	$35K	0.0%	N/A	0.012%
2/5/2024	Victory Capital Management Inc.	10,099	$29K	0.0%	N/A	0.010%
2/1/2024	Powell Investment Advisors LLC	21,000	$60K	0.0%	+75.0%	0.020%
1/30/2024	United Asset Strategies Inc.	221,308	$0.63M	0.1%	+53.9%	0.214%
1/30/2024	Imprint Wealth LLC	39,703	$0.12M	0.1%	-15.7%	0.038%
1/24/2024	China Universal Asset Management Co. Ltd.	11,986	$34K	0.0%	+350.4%	0.012%
1/12/2024	SG Americas Securities LLC	16,340	$46K	0.0%	+52.8%	0.016%
1/11/2024	Whittier Trust Co. of Nevada Inc.	10,000	$28K	0.0%	N/A	0.010%
11/15/2023	GSA Capital Partners LLP	355,918	$1.04M	0.1%	+139.5%	0.344%
11/15/2023	Rokos Capital Management LLP	200,000	$0.59M	0.0%	+122.5%	0.193%
11/14/2023	Clough Capital Partners L P	79,309	$0.23M	0.0%	N/A	0.077%
11/13/2023	Bay Colony Advisory Group Inc d b a Bay Colony Advisors	17,950	$53K	0.0%	N/A	0.017%
11/7/2023	United Asset Strategies Inc.	143,808	$0.42M	0.1%	-21.8%	0.139%
11/7/2023	Hamilton Lane Advisors LLC	21,893	$64K	0.0%	-58.5%	0.021%
11/7/2023	Barclays PLC	23,788	$70K	0.0%	-66.4%	0.023%
11/3/2023	Private Advisor Group LLC	94,980	$0.28M	0.0%	+126.1%	0.092%
10/30/2023	Private Management Group Inc.	15,500	$45K	0.0%	N/A	0.015%
10/23/2023	Commonwealth Equity Services LLC	12,580	$37K	0.0%	N/A	0.012%
10/16/2023	Powell Investment Advisors LLC	12,000	$35K	0.0%	N/A	0.012%
10/13/2023	SG Americas Securities LLC	10,695	$31K	0.0%	N/A	0.010%
9/12/2023	Davidson Kempner Capital Management LP	450,000	$1.28M	0.0%	N/A	0.435%
8/14/2023	Luminus Management LLC	400,000	$1.14M	0.3%	N/A	0.387%
8/14/2023	Shay Capital LLC	50,236	$0.14M	0.0%	+151.3%	0.049%
8/10/2023	Private Advisor Group LLC	42,000	$0.12M	0.0%	+42.4%	0.041%
7/31/2023	Curi Wealth Management LLC	35,440	$0.10M	0.0%	N/A	0.034%
7/31/2023	LPL Financial LLC	316,140	$0.90M	0.0%	+13.4%	0.306%
7/25/2023	United Asset Strategies Inc.	183,960	$0.53M	0.1%	+212.0%	0.178%
7/24/2023	Allspring Global Investments Holdings LLC	26,665	$76K	0.0%	+61.8%	0.026%
7/21/2023	Kovack Advisors Inc.	40,000	$0.11M	0.0%	+14.3%	0.039%
7/18/2023	Allspring Global Investments Holdings LLC	26,665	$76K	0.0%	+61.8%	0.026%
5/11/2023	Kovitz Investment Group Partners LLC	11,250	$35K	0.0%	N/A	0.011%
5/9/2023	Y Intercept Hong Kong Ltd	14,565	$45K	0.0%	N/A	0.014%
4/28/2023	SG Americas Securities LLC	29,921	$92K	0.0%	N/A	0.029%
4/25/2023	United Asset Strategies Inc.	58,960	$0.18M	0.0%	+114.7%	0.057%
4/21/2023	Kovack Advisors Inc.	35,000	$0.11M	0.0%	+40.0%	0.034%
4/14/2023	Raymond James & Associates	19,411	$60K	0.0%	N/A	0.019%
4/13/2023	Allspring Global Investments Holdings LLC	16,479	$51K	0.0%	N/A	0.016%
3/23/2023	MetLife Investment Management LLC	34,928	$74K	0.0%	N/A	0.034%
2/22/2023	Kovack Advisors Inc.	25,000	$53K	0.0%	N/A	0.024%
2/13/2023	The Manufacturers Life Insurance Company	15,218	$32K	0.0%	N/A	0.015%
2/7/2023	LPL Financial LLC	284,540	$0.60M	0.0%	-9.1%	0.276%
2/2/2023	ProShare Advisors LLC	16,093	$34K	0.0%	+51.7%	0.016%
2/1/2023	Gladstone Institutional Advisory LLC	12,098	$26K	0.0%	-86.2%	0.012%
1/26/2023	United Asset Strategies Inc.	27,460	$58K	0.0%	+83.6%	0.027%
1/18/2023	Private Advisor Group LLC	29,500	$62K	0.0%	+20.4%	0.029%
11/14/2022	Ergoteles LLC	31,276	$0.10M	0.0%	N/A	0.030%

Data available starting January 2016

Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.

Today's Range

Now: $4.41

$4.29

$4.57

50 Day Range

MA: $5.38

$4.42

$6.12

52 Week Range

Now: $4.41

$2.43

$9.97

Volume

2,094,875 shs

Average Volume

2,412,612 shs

Market Capitalization

$555.04 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.47

Who are the company insiders with the largest holdings of Humacyte?: Humacyte's top insider investors include:
Laura E Niklason (CEO)
Brady W Dougan (Director)
Gordon M Binder (Director)
Heather Ledbetter Prichard (COO)
Kathleen Sebelius (Director)
Dale A Sander (CFO)
William John Scheessele (Insider)
Learn More about top insider investors at Humacyte.
Who are the major institutional investors of Humacyte?: Humacyte's top institutional shareholders include:
State Street Corp — 3.99%
Geode Capital Management LLC — 1.71%
Charles Schwab Investment Management Inc. — 0.60%
Private Advisor Group LLC — 0.31%
Wellington Management Group LLP — 0.21%
Barclays PLC — 0.20%
Learn More about top institutional investors of Humacyte stock.
Which major investors are selling Humacyte stock?: In the last quarter, HUMA stock was sold by these institutional investors:
GSA Capital Partners LLP
Virtu Financial LLC
Within the last year, company insiders that have sold Humacyte company stock include:
Laura E Niklason (CEO)
Brady W Dougan (Director)
Gordon M Binder (Director)
Heather Ledbetter Prichard (COO)
Kathleen Sebelius (Director)
Learn More investors selling Humacyte stock.
Which major investors are buying Humacyte stock?: In the previous quarter, HUMA stock was purchased by institutional investors including:
State Street Corp
Geode Capital Management LLC
Barclays PLC
Barclays PLC
Thrivent Financial for Lutherans
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Verition Fund Management LLC
Charles Schwab Investment Management Inc.
In the last year, these company insiders have bought Humacyte stock:
Laura E Niklason (CEO)
Brady W Dougan (Director)
Gordon M Binder (Director)
Heather Ledbetter Prichard (COO)
Kathleen Sebelius (Director)
Learn More investors buying Humacyte stock.